logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Calmvik, Jacob
    Ceo Of Avia Pharma Ab born in August 1977
    Individual (1 offspring)
    Officer
    icon of calendar 2024-09-11 ~ now
    OF - Director → CIF 0
  • 2
    Mcglynn, Gabriel Thomas
    Pharmaceutical Consultant born in September 1947
    Individual (4 offsprings)
    Officer
    icon of calendar 2013-12-06 ~ now
    OF - Director → CIF 0
    Mr Gabriel Thomas Mcglynn
    Born in September 1947
    Individual (4 offsprings)
    Person with significant control
    icon of calendar 2016-04-06 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
Ceased 1
  • Neubourg, Thomas, Dr
    Self Employed born in February 1969
    Individual
    Officer
    icon of calendar 2014-09-08 ~ 2025-01-02
    OF - Director → CIF 0
    Dr Thomas Neubourg
    Born in February 1969
    Individual
    Person with significant control
    icon of calendar 2016-04-06 ~ 2025-01-02
    PE - Ownership of shares – More than 25% but not more than 50% as a member of a firmCIF 0
parent relation
Company in focus

NEUBOURG PHARMA (UK) LIMITED

Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Property, Plant & Equipment
33 GBP2024-12-31
45 GBP2023-12-31
Cash at bank and in hand
18,859 GBP2024-12-31
77 GBP2023-12-31
Creditors
Amounts falling due within one year
-53,056 GBP2024-12-31
-144,942 GBP2023-12-31
Net Current Assets/Liabilities
-34,197 GBP2024-12-31
-144,865 GBP2023-12-31
Net Assets/Liabilities
-34,164 GBP2024-12-31
-144,820 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
1,596 GBP2024-12-31
1,596 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
1,563 GBP2024-12-31
1,551 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
12 GBP2024-01-01 ~ 2024-12-31
Number of shares allotted
Class 1 ordinary share
100 shares2024-01-01 ~ 2024-12-31
Par Value of Share
Class 1 ordinary share
1 GBP2024-01-01 ~ 2024-12-31
Nominal value of allotted share capital
Class 1 ordinary share
100 GBP2024-01-01 ~ 2024-12-31
100 GBP2023-01-01 ~ 2023-12-31
Average Number of Employees
12024-01-01 ~ 2024-12-31
12023-01-01 ~ 2023-12-31

  • NEUBOURG PHARMA (UK) LIMITED
    Info
    Registered number 08804774
    icon of addressSwift House, Ground Floor, 18 Hoffmanns Way, Chelmsford, Essex CM1 1GU
    PRIVATE LIMITED COMPANY incorporated on 2013-12-06 (12 years 1 month). The company status is Active.
    The last date of confirmation statement was made at 2024-12-06
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.